Shockwave Therapy for Erectile Dysfunction

(REVIVE Trial)

This trial explores a new treatment option for men experiencing erectile dysfunction after prostate cancer surgery. It tests whether adding low-intensity extracorporeal shockwave therapy (LiESWT), a non-invasive treatment using gentle shockwaves, can improve blood flow and tissue recovery. Participants will receive either standard penile rehabilitation or the standard treatment plus LiESWT. Men who have undergone nerve-sparing prostate cancer surgery and are experiencing erectile dysfunction may be suitable candidates for this trial. The goal is to determine if LiESWT increases the chances of regaining normal erectile function 24 weeks after surgery. As an unphased trial, this study offers a unique opportunity to explore innovative treatments that could enhance recovery and improve quality of life.

Research has shown that Low-Intensity Extracorporeal Shockwave Therapy (LiESWT) is generally safe for treating erectile dysfunction. Studies indicate that patients tolerate this treatment well. For instance, a review found significant improvements in erectile function with no reported side effects. Another study observed lasting benefits in patients up to 18 months after treatment, again with no negative effects. Overall, LiESWT appears to be a safe option, with evidence suggesting it can improve blood flow and aid tissue recovery without causing harm.¹²³⁴⁵

Low-Intensity Extracorporeal Shockwave Therapy (LiESWT) is unique because it uses sound waves to improve blood flow, which is different from most standard treatments for erectile dysfunction like oral medications (such as Viagra or Cialis) that primarily increase blood flow temporarily. Researchers are excited about LiESWT because it targets the root cause of erectile dysfunction by promoting tissue regeneration and improving vascular function over time. This therapy could offer a longer-lasting solution without the need for daily medication. Plus, it involves a non-invasive, quick procedure that could be more convenient for many patients.

This trial will compare low-intensity extracorporeal shockwave therapy (LiESWT) combined with standard postoperative penile rehabilitation to standard care alone. Studies have shown that LiESWT can improve erectile function, with patients experiencing an average 4-point increase in their erectile function scores. Research indicates that these benefits can last for more than six months. In some studies, up to 79% of patients noticed a significant improvement in erectile function after three months. This therapy likely works by boosting blood flow and aiding tissue recovery, both crucial for erectile function.⁶⁷⁸⁹¹⁰